284 related articles for article (PubMed ID: 16219607)
1. Neurolytic celiac plexus block: a better alternative to opioid treatment in upper abdominal malignancies: an Indian experience.
Jain PN; Shrikhande SV; Myatra SN; Sareen R
J Pain Palliat Care Pharmacother; 2005; 19(3):15-20. PubMed ID: 16219607
[TBL] [Abstract][Full Text] [Related]
2. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain.
de Oliveira R; dos Reis MP; Prado WA
Pain; 2004 Jul; 110(1-2):400-8. PubMed ID: 15275792
[TBL] [Abstract][Full Text] [Related]
3. Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain.
Huang L; Tao F; Wang Z; Wan H; Qu P; Zheng H
J BUON; 2014; 19(3):826-30. PubMed ID: 25261674
[TBL] [Abstract][Full Text] [Related]
4. Assessment of consecutive neurolytic celiac plexus block (NCPB) technique outcomes in the management of refractory visceral cancer pain.
Yang FR; Wu BS; Lai GH; Wang Q; Yang LQ; He MW; Ni JX
Pain Med; 2012 Apr; 13(4):518-21. PubMed ID: 22360763
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain.
Süleyman Ozyalçin N; Talu GK; Camlica H; Erdine S
Eur J Pain; 2004 Dec; 8(6):539-45. PubMed ID: 15531222
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy.
Stefaniak T; Basinski A; Vingerhoets A; Makarewicz W; Connor S; Kaska L; Stanek A; Kwiecinska B; Lachinski AJ; Sledzinski Z
Eur J Surg Oncol; 2005 Sep; 31(7):768-73. PubMed ID: 15923103
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer.
Polati E; Finco G; Gottin L; Bassi C; Pederzoli P; Ischia S
Br J Surg; 1998 Feb; 85(2):199-201. PubMed ID: 9501815
[TBL] [Abstract][Full Text] [Related]
8. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial.
Wong GY; Schroeder DR; Carns PE; Wilson JL; Martin DP; Kinney MO; Mantilla CB; Warner DO
JAMA; 2004 Mar; 291(9):1092-9. PubMed ID: 14996778
[TBL] [Abstract][Full Text] [Related]
9. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer.
Plancarte R; de Leon-Casasola OA; El-Helaly M; Allende S; Lema MJ
Reg Anesth; 1997; 22(6):562-8. PubMed ID: 9425974
[TBL] [Abstract][Full Text] [Related]
10. [Analgesic effect of neurolytic celiac plexus block guided by ultrasonography in advanced malignancies].
Chen M; Hao C; Zhang H
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):418-21. PubMed ID: 11798910
[TBL] [Abstract][Full Text] [Related]
11. Neurolytic celiac plexus block for pancreatic cancer pain.
Brown DL; Bulley CK; Quiel EL
Anesth Analg; 1987 Sep; 66(9):869-73. PubMed ID: 3619093
[TBL] [Abstract][Full Text] [Related]
12. Comparative study between 2 protocols for management of severe pain in patients with unresectable pancreatic cancer: one-year follow-up.
Amr YM; Makharita MY
Clin J Pain; 2013 Sep; 29(9):807-13. PubMed ID: 23917696
[TBL] [Abstract][Full Text] [Related]
13. The superficial cervical plexus block for postoperative pain therapy in carotid artery surgery. A prospective randomised controlled trial.
Messner M; Albrecht S; Lang W; Sittl R; Dinkel M
Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):50-4. PubMed ID: 16962799
[TBL] [Abstract][Full Text] [Related]
14. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
[TBL] [Abstract][Full Text] [Related]
15. Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain.
Zhang CL; Zhang TJ; Guo YN; Yang LQ; He MW; Shi JZ; Ni JX
Dig Dis Sci; 2008 Mar; 53(3):856-60. PubMed ID: 17676392
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of neurolytic celiac plexus block for nonpancreatic intra-abdominal cancer pain.
Brown DL
Reg Anesth; 1989; 14(2):63-5. PubMed ID: 2487665
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief.
Rykowski JJ; Hilgier M
Anesthesiology; 2000 Feb; 92(2):347-54. PubMed ID: 10691219
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
19. The role of neurolytic celiac plexus block in the treatment of pancreatic cancer pain.
Polati E; Luzzani A; Schweiger V; Finco G; Ischia S
Transplant Proc; 2008 May; 40(4):1200-4. PubMed ID: 18555148
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
